Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
about
sameAs
Non-invasive parenchymal, vascular and metabolic high-frequency ultrasound and photoacoustic rat deep brain imaging.Photoacoustic Brain Imaging: from Microscopic to Macroscopic ScalesPhotoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivoInfluence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures.Mesenchymal migration as a therapeutic target in glioblastoma.Potential applications of magnetic particles to detect and treat Alzheimer's disease.MRI study on reversible and irreversible electroporation induced blood brain barrier disruptionNeuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged ratsNovel central nervous system drug delivery systems.Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviorsMultifunctional nanoagent for thrombus-targeted fibrinolytic therapy.The involvement of microglial cells in Japanese encephalitis infections.Gold nanoparticles as multimodality imaging agents for brain gliomasGlyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailabilityTargeted drug delivery for treatment and imaging of glioblastoma multiforme.Pharmacological treatment for heart failure: a view from the brain.NanoART, neuroAIDS and CNS drug delivery.Mixed polyethylene glycol-modified breviscapine-loaded solid lipid nanoparticles for improved brain bioavailability: preparation, characterization, and in vivo cerebral microdialysis evaluation in adult Sprague Dawley rats.Cancer immunotherapy and nanomedicine.Challenges in development of nanoparticle-based therapeutics.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.Nano-enabled delivery systems across the blood-brain barrier.Etiology and pathogenesis of late-onset Alzheimer's disease.An overview of the biological and psychosocial context surrounding neurocognition in HIV.Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge.Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.Acute exposure to zinc oxide nanoparticles does not affect the cognitive capacity and neurotransmitters levels in adult rats.Effects of nanoparticle zinc oxide on emotional behavior and trace elements homeostasis in rat brain.Neuroprotective effects of three different sizes nanochelating based nano complexes in MPP(+) induced neurotoxicity.Iron Oxide Nanoparticle Delivery of Peptides to the Brain: Reversal of Anxiety during Drug Withdrawal.The effect of iron nanoparticles on performance of cognitive tasks in rats.Different particulate systems--bypass the biological barriers?Dendrimer D5 is a vector for peptide transport to brain cells.Alumina nanoparticles alter rhythmic activities of local interneurons in the antennal lobe of Drosophila.Titanium dioxide nanoparticles induced intracellular calcium homeostasis modification in primary human keratinocytes. Towards an in vitro explanation of titanium dioxide nanoparticles toxicity.Magnetic Targeting of Growth Factors Using Iron Oxide Nanoparticles
P2860
Q30413646-9F2254E9-F557-4F1F-BA14-FDCD265B7E8CQ30426250-84239699-DAE8-46FD-9341-5DEE0925E9ECQ30437587-E1F62794-30B7-4298-AD03-CCC91BD2EC60Q30475459-CA2A2D8E-24C6-430E-8ED6-2992279FED1FQ34002994-7CA82DBD-9745-4037-B62D-C3FEDAF66BD4Q34289125-9EC5B7BF-D505-4230-9A45-30527C7AF032Q34382616-3CE5EE86-0484-4E8E-AA3F-398ED47EAFAAQ34688621-FF8BA533-EDD6-4BDB-9648-5670B8413D01Q35064473-CEA74C8D-E299-4C8B-B52E-C2F1775CCFA2Q35834280-38A05C17-6B63-441C-B4D0-B3E85CFCCF0FQ35987760-C0F968CD-12A5-4EE3-A7F9-D28212771597Q36167789-85E4AAA2-35FA-4455-9488-348B85911158Q36304256-532A03AA-7B75-4F04-9FE2-233C3CDD837EQ36776398-F449769F-1425-4AF6-ACD3-0D10899A2B44Q37112313-7C6BC92D-1121-4E19-8517-0CBEC1DD4A34Q37523966-F74F9637-3F0B-4DEF-B28A-16C2C14898E7Q37530428-2456C99C-AFB9-4D1D-8C31-9374E380CDB2Q37538776-A55FC791-FCB1-4654-BF37-7B59DCA3EF96Q37671850-70504383-D4D3-48AD-9726-74E58AD69D7EQ37785836-6ACF4170-E7E6-413C-9593-43B7C8B08D72Q37992525-49F5E62F-103E-4CAF-87E9-442E1DBAD575Q37995554-03AB8ADD-AADE-4EF0-8B53-7659FAED0499Q38130176-863123B6-EDA4-49E9-A3FD-815A521E7BBEQ38156382-7B53B90E-D133-4B33-AA4C-BEFC553720CDQ38178837-5545B404-6E3C-476A-8B4C-B12AC2FB0450Q38203412-CCA39292-1E13-4129-88F5-746A53D69B8FQ38884364-D39B2803-4F37-4410-9293-E4F20E04CFB6Q39202721-F4F47AC5-5469-4736-B5A0-32DE3D07D2C3Q39479822-CAB1F7D0-FAB1-41D8-8451-AE1AC68368CCQ42643098-283779E4-CA3D-47B1-9567-3E211AB13F02Q46140274-58174469-9099-46AD-A935-878387746E13Q46806558-5D0CC248-61A7-4149-B500-D7E482B140D2Q47110352-24AFCFE6-059C-4A6C-9C31-D52B3BEA7A31Q48304626-CC6876D8-8908-480B-8C4B-6DDA4B47D8FFQ48419057-410BE183-8C88-460F-9F04-ADEFB067807CQ48696940-9F89296D-0F05-4144-A4E6-176756CC73E3Q48700922-B671A381-6900-476E-8F0E-D4CE09215725Q50684622-6B0D756F-686F-4117-B964-86BDFFCBD20EQ58753405-2D8BBE4A-876C-41AA-926F-BC7FE53ABFDD
P2860
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@ast
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en-gb
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@nl
type
label
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@ast
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en-gb
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@nl
prefLabel
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@ast
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en-gb
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@nl
P2860
P921
P3181
P1433
P1476
Nanotechnology approaches to c ...... r and drug delivery to the CNS
@en
P2093
Gabriel A Silva
P2860
P2888
P3181
P356
10.1186/1471-2202-9-S3-S4
P407
P433
P577
2008-12-10T00:00:00Z
P5875
P6179
1043899569